DarukaMahadevanMD

Oncology • San Antonio, TX

Associate Professor, Medicine, University of Arizona College of Medicine

Join to view full profile

Dr. Mahadevan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mahadevan's full profile

Already have an account?

Office
7979 Wurzbach Rd
San Antonio, TX 78229
Phone+1 210-450-1143

Fax+1 210-450-0407

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2000 - 2002
University of ConnecticutResidency, Internal Medicine, 1994 - 1997
Guy's, King's and St Thomas' School of Medical EducationClass of 1990

Certifications & Licensure

TX State Medical License 2020 - 2025
AZ State Medical License 2002 - 2021
TN State Medical License 2012 - 2017
MS State Medical License 2013 - 2016
CT State Medical License 1998 - 2003
American Board of Internal Medicine Medical Oncology

Clinical Trials

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 Sep 01
Completed
Phase 2
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors Start of enrollment: 2008 May 01
Completed
Phase 1
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies Start of enrollment: 2011 Jun 01
Completed
Phase 1
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Start of enrollment: 2011 Oct 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments.
Patrick J Conway, Jonathan Dao, Dmytro Kovalskyy, Daruka Mahadevan, Eloise Dray
Molecular Cancer Therapeutics. 2024-05-02
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
Gregory A Vidal, Patricia Chalela, Andrea N Curry, Bassel El-Rayes, Balazs Halmos
Contemporary Clinical Trials. 2024-02-01
(HER2) amplifications and co-occurringalterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, Victoria M Raymond, Andrea Wang-Gillam
Frontiers in Oncology. 2024-01-01

Journal Articles

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b Study
Karen Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell Lymphoma
Daniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research

Lectures

Multi-Omics of Aurora Inhibition Induced Polyploidy Reveals Mechanisms of Disease Relapse in MYC/BCL2-Addicted High Grade B-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Researchers Look to Bring New Blood Tests for Cancer to MarketMay 26th, 2019
Immunotherapy—Cancer's New FrontierApril 5th, 2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member